FdaApplication
NDA 020729
Identifiers
- fda_app_no: NDA020729
Properties
| Property | Value |
|---|---|
| applicant_name | UCB INC |
| application_type | NDA |
| approval_date | 1997-06-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| UNIRETIC | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE | 12.5MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| UNIRETIC | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE | 12.5MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| UNIRETIC | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE | 25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
3 products